Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric W Bow

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Perspectives in Medicinal Chemistry|July 12, 2016
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 ModulationEric W Bow, John M Rimoldi
Molecular Pharmaceutics|August 14, 2020
Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl AnaloguesRodell C Barrientos, Eric W Bow, Connor Whalen, et al.
Bioconjugate Chemistry|June 2, 2021
Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in MiceRodell C Barrientos, Connor Whalen, Oscar B Torres, et al.
Pharmacology Research & Perspectives|June 29, 2023
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacyEdna J Santos, Nima Nassehi, Eric W Bow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2024
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in MiceEdna J Santos, Hamid I Akbarali, Eric W Bow, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphansJoshua A Lutz, Agnieszka Sulima, Eugene S Gutman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Perspectives in Medicinal Chemistry|July 12, 2016
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 ModulationEric W Bow, John M Rimoldi
Molecular Pharmaceutics|August 14, 2020
Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl AnaloguesRodell C Barrientos, Eric W Bow, Connor Whalen, et al.
Bioconjugate Chemistry|June 2, 2021
Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in MiceRodell C Barrientos, Connor Whalen, Oscar B Torres, et al.
Pharmacology Research & Perspectives|June 29, 2023
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacyEdna J Santos, Nima Nassehi, Eric W Bow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2024
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in MiceEdna J Santos, Hamid I Akbarali, Eric W Bow, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphansJoshua A Lutz, Agnieszka Sulima, Eugene S Gutman, et al.
Pageof 1